Brean Murray Lowers PT on InterMune to $42

Symbols: ITMN
Share

Brean Murray Carret & Company has lowered the price target on InterMune (NASDAQ: ITMN) from $50 to $42 and maintains its Buy rating.


 
 
< Previous
Brean Murray Raises PT on Alpha Natural Resources to $35
Next >
Bank of America Raises PO on Starbucks to $48
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust